Business Wire

leon Secures Series B Funding to Accelerate Growth in Enabling Nano Now, While Establishing Strategic Partnership with Evotec


leon-nanodrugs GmbH, the leading enabler of nano technology for the pharmaceutical industry, announced today that it has successfullycompleted a Series B funding round. The capital will be used to further strengthen the company’s leadership position in the provision of nano solutions for the pharmaceutical and biotechnology industries.

Under a separate partnership agreement, Evotec and leon will leverage their combined expertise in nano-medicine development services, providing clients with world class, end to end opportunities within the CDMO sector. Together, the partnership will maximize the effectiveness of clinical and commercial nano-medicine development and co-operate on carefully selected development programs.

Andrea Cusack, CEO of leon commented “We are at the forefront of innovation in the international pharmaceutical market, leading the way in nano formulation of API’s. The strategic partnership with Evotec enables us to exploit the value of our technology and deliver a solution to clients from concept to GMP, successfully delivering products to market”

Dr Werner Lanthaler, Chief Executive Officer of Evotec, said: “We are excited about this new strategic collaboration with leon-nanodrugs. leon’s proprietary technology has the potential to be a game changer for the formulation, development and production of efficient drugs and will drive innovation efficiency by directly improving clinical outcomes. Our joint efforts in nanomedicine will ultimately benefit a large number of patients across a broad range of indications with significant unmet medical need.”

Christian Nafe, CFO of leon on the successful completion of the financing round: "We are encouraged by the positive participation of our new investors and the continued support of our existing consortium. This Series B funding will help us execute our strategy and bring products from the platform to the clinic.”

The investors come from right across the life sciences space, bringing a wealth of expertise and experience and includes TVM Life Science Innovation I.L.P., CD-Venture GmbH, Albany Private Equity Holdings Pty Ltd, Eckenstein-Geigy-Stiftung, LOF Leon Partnership, L.P., Evotec SE and BayBG.

Enno Spillner, CFO of Evotec and Dr. Peter Graf, Investment Manager of BayBG will join a peer recognized supervisory board which includes Dr. Hubert Birner (Managing Partner of TVM Life Science Venture Capital), Dr Gerhard Ries (LifeCare Partners), James C. Gale (Signet Healthcare Partners) and Dr. Frank Mathias (Rentschler Biotechnologie GmbH).

It is estimated that over 80% of pharmaceutical pipeline API’s are poorly soluble in water. Leon expedites Active Pharmaceutical Ingredients (APIs) to deliver improved stability, increased solubility and enhanced bioavailability, the benefits of which is lower dose, greater payload and faster onset. Leon’s novel validated and optimized solutions therefore create value for virtual companies and multinational Pharmaceutical organizations and ultimately provide better outcomes for patients.

About leon

leon delivers novel, validated and optimized solutions that create value for clients and provide better outcomes for their patients. It expedites API’s to deliver enhanced bioavailability, increased solubility and improved stability, revitalizing forgotten formulations, and breathing new life into generics.

leon’s proprietary* technology platforms offer access to the next generation of SMART nanoparticles™ and nano-formulated drugs, adding value at every stage of the chain from partners and payers to caregivers and patients.

* MicroJet Reactor (MJR)

Contact information

For more information
Andrea Cusack
leon-nanodrugs GmbH
T +49 (89) 41 42 488 981

About Business Wire

Business Wire
Business Wire

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Researcher John Craig Venter Is Awarded the 2020 Edogawa-NICHE Prize for His Accomplishment in Human Genome Research15.8.2020 08:00:00 CESTPress release

The Edogawa NICHE Prize for the year 2020 has been awarded to Dr. John Craig Venter for his contribution to research and development pertaining to the Human genome. This honor reflects Dr. Venter's lifetime accomplishments in the power of the genomics and specifically in the identification of the human genome which has radically transformed healthcare according to Prof. Gary Levy, chair, Edogawa NICHE awards committee ( This press release features multimedia. View the full release here: Dr. John Craig Venter, recipient of the 2020 - Edogawa NICHE Prize, for his contribution to research and development pertaining to the Human genome. (Photo: Business Wire) Edogawa NICHE Prize was Instituted in 2018, by the Jinseisha trust, and the Nichi-In Centre for Regenerative Medicine (NCRM), which honours scientists or clinicians whose contributions lead to the development of prevention, diagnosis or treatment of a

Eaton Launches New Line of Wireless Mobile Control Solutions for Heavy Machinery and Field Operations13.8.2020 23:51:00 CESTPress release

Power management company Eaton today announced its eMobility business has launched a new and improved line of Eaton OMNEX Trusted Wireless™ mobile control solutions for heavy machinery and field operations. The 900 MHz two-way remote-control units allow for the wireless control of high-value machinery in harsh environments, including mining, construction, agriculture, locomotive and marine markets. This press release features multimedia. View the full release here: Eaton's new OMNEX Trusted Wireless™ controllers can remotely operate heavy machinery, such as vacuum trucks, tow trucks, concrete mixers and cranes. (Photo: Business Wire) “Our next generation of rugged, weatherproof OMNEX wireless controllers were designed with customer input, and offer a number of benefits, including enhanced safety and productivity for machine operators,” said Scott Adams, president, eMobility, Eaton. “Overall, we’ve improved upon the reliability a

IFF to Hold Virtual Special Meeting of Shareholders on August 2713.8.2020 22:15:00 CESTPress release

Regulatory News: IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of taste, scent, and nutrition, announced today that the previously communicated special meeting of shareholders to consider and vote on the issuance of shares of IFF common stock in connection with the previously announced proposed merger of IFF and DuPont’s Nutrition & Biosciences (“N&B”) business pursuant to a Reverse Morris Trust transaction (the “special meeting”) has been changed to a virtual-only meeting due to the continued public health concerns over the COVID-19 outbreak and the health and safety of its shareholders and employees. Accordingly, the special meeting, to be held on Thursday, August 27, 2020 at 10:00 a.m. Eastern Time, will be held only virtually on the Internet at Shareholders will not be able to attend the meeting or vote physically in person. We have designed the format of the special meeting to provide shareholders the same right

PTC Makes Enterprise Version of Onshape Education Suite Available Free of Charge13.8.2020 22:00:00 CESTPress release

In advance of the 2020-2021 school year, PTC (NASDAQ: PTC) has made the Onshape® Education Suite’s newly-released Enterprise plan available free-of-charge for K-12 schools and universities that register through November 20, 2020. The newest version of the cloud-based, remote learning suite is offered alongside the Onshape Education Standard plan to help alleviate the burden experienced by educational STEM programs during the COVID-19 pandemic. This press release features multimedia. View the full release here:

DeltaTrak Enhances Its Cold Chain Restart Program to Help Customers Battle COVID-1913.8.2020 18:00:00 CESTPress release

DeltaTrak®, a leading innovator of cold chain solutions, is enhancing its Cold Chain Restart Program to offer customers safer and more efficient methods to protect their employees and clients from the COVID-19 pandemic. The program was created to help companies reopen on a safe footing by providing access to critically needed PPE solutions. Following an extremely positive response, DeltaTrak has added the ThermoTrace Auto-Check Non-Contact Infrared Forehead Thermometer and Touchless Hand Sanitizer Dispenser to address the need for effective, contactless and hands-free options for temperature measurement and sanitization. “The increased demand for safety and sanitization equipment is driven by our customers’ need to conduct business safely without jeopardizing the health of employees and customers when it comes to using thermometers and hand sanitizers,” said Frederick Wu, President and CEO of DeltaTrak. “Gaining access to these solutions remains a major challenge and we are confident t

Verimatrix to Sponsor Virtual SportsPro Media INSIDER Series Featuring Broadcasting Experts From the NFL, Octagon, Astro, The FA, European Tour & More13.8.2020 17:35:00 CESTPress release

Regulatory News: Verimatrix (Paris:VMX) (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Chief Revenue Officer Lu Bolden will join a lineup of sports broadcasting experts to speak on the future of the industry with today’s new need to protect ever-growing amounts of streamed sports and esports. Registration is free. Visit With an eye on highlighting the largely unchartered challenges that come with new methods of reaching all types of sports fans, the SportsPro Media INSIDER Series serves as a valuable venue for those seeking to protect revenues when fans are at home instead of stadiums. Traditional sports have found themselves facing the same new business model decisions that esports has organically addressed over the last several years. That makes for a big shift – where new revenue streams are created at warp speed with various streaming and broadcast options for countless typ

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom